AST SpaceMobile's Stock Is Down After Another Successful Launch: Time to Buy The Dip?

AST SpaceMobile launched BlueBird satellites 8, 9, and 10 and said BlueBirds 11, 12, and 13 are in final preparation, with production already underway through BlueBird 37. Management is targeting 45 to 60 satellites in orbit by end-2026 and as many as 248 over the next few years, supporting analyst forecasts for revenue to rise from $71 million in 2025 to $1.88 billion in 2028. The stock remains about 35% below its all-time high, and the article argues the valuation may be reasonable at 13x projected 2028 sales versus 136x current-year sales.

Analysis

The key market read is not that launch cadence is improving, but that AST is now transitioning from a concept-risk story to an execution-risk story. That matters because once investors believe the platform works, the stock starts trading on confidence in manufacturing yield, deployment cadence, and ground-network integration rather than on novelty; in that regime, any slip in ship cadence or certification can compress the multiple fast even if the long-term TAM remains intact.

The second-order beneficiary is the carrier ecosystem, especially AT&T and Verizon, because AST’s model effectively extends coverage economics without forcing the same capex burden as tower densification in low-density markets. The less obvious pressure point is on terrestrial tower vendors and rural fixed-wireless substitutes: if AST proves it can deliver acceptable uptime and latency, carriers may delay some incremental rural capex, which shifts bargaining power away from infrastructure owners toward operators. That also creates a hardware supply-chain bottleneck trade: any delay in launch slots, payload integration, or manufacturing yields becomes the dominant near-term risk rather than demand.

The consensus is underestimating how binary the next 6-12 months are. This is not a straight-line growth trade; it is a milestone trade where investor psychology will swing on visible satellite-in-orbit counts, initial service quality, and whether commercial revenue starts to look repeatable enough to justify the 2027 EBITDA inflection. The valuation is only "reasonable" if the market grants AST a long-duration software-like multiple before the revenue bridge is proven — that is a fragile assumption in a higher-rate regime.

The contrarian setup is that the stock may already be pricing in too much of the good news from launches while still underpricing funding and dilution risk. If AST needs repeated equity raises to bridge from engineering success to cash-flow breakeven, the equity can lag even as the product narrative improves. Conversely, if management can demonstrate tight launch execution and pre-sold capacity, the stock could re-rate sharply because short interest and skepticism remain a fuel source for upside.

Key Decisions for Investors

• Maintain a tactical long ASTS position only on pullbacks; prefer staged entries over chasing strength until BlueBird deployment cadence proves consistent over the next 1-2 launch windows.
• Buy ASTS Jan-2027 call spreads to express upside from the 2026-2027 commercialization inflection while capping dilution/financing downside; best risk/reward if implied volatility eases after launch excitement fades.
• Pair trade: long ASTS / short a basket of rural telecom capex proxies or tower-exposed names if AST service milestones continue to validate coverage substitution; thesis is relative capex displacement over 6-12 months.
• Use a tight risk stop on ASTS around any missed launch or integration milestone; this is an execution-sensitive name where a single delay can reprice the stock 15-25% quickly.
• For conservative accounts, prefer a small long in VZ over ASTS as a lower-beta way to play eventual network extension economics, but only if you want exposure to the customer side rather than the binary satellite execution story.